Citius Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.71

-0.04 (-5.48%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +442.3% upside

Low Target $3.27

Average Target $3.85

High Target $6.37

Current Price $0.71

Current
$0.71

Target
$3.85

$3.27 $3.85 avg $6.37

Scenario Analysis

Bear Case

$3.27

360.6%

Low target

Base Case

$3.85

+442.3%

Avg target

Bull Case

$6.37

+797.2%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$2.48

-71.4% from high

52-Week Low

$0.63

+12.7% from low

Target vs 52W High

$3.85

+55.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%